Bright Minds Biosciences (DRUG) Institutional Ownership $50.25 -0.73 (-1.43%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Bright Minds Biosciences (NASDAQ:DRUG)CurrentInstitutional OwnershipPercentage40.52%Number ofInstitutional Buyers(last 12 months)23TotalInstitutional Inflows(last 12 months)$80.54MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$18.05M Get DRUG Insider Trade Alerts Want to know when executives and insiders are buying or selling Bright Minds Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data DRUG Institutional Buying and Selling by Quarter Bright Minds Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Perceptive Advisors LLC420,690$10.98M1.0%-5.4%5.976% 8/15/2025 Bank of America Corp DE4,734$124K0.0%-12.6%0.067% 8/14/2025 Acuta Capital Partners LLC48,474$1.27M1.8%-18.9%0.688% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2,513$66K0.0%N/A0.036% 8/13/2025 Walleye Capital LLC53,430$1.40M0.0%-37.2%0.759% 8/13/2025 Sio Capital Management LLC512,338$13.38M5.1%+0.9%7.278% 8/13/2025 New York State Common Retirement Fund4,100$107K0.0%N/A0.058% 8/12/2025 JPMorgan Chase & Co.2,173$57K0.0%+624.3%0.031% 8/8/2025 Police & Firemen s Retirement System of New Jersey1,079$28K0.0%N/A0.015% 8/8/2025 Geode Capital Management LLC57,521$1.50M0.0%N/A0.817% Get the Latest News and Ratings for DRUG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/4/2025 AdvisorShares Investments LLC14,481$378K0.1%+28.4%0.206% 6/27/2025 Goldman Sachs Group Inc.22,222$802K0.0%N/A0.316% 5/16/2025Goldman Sachs Group Inc.22,222$802K0.0%N/A0.315% 5/16/2025Millennium Management LLC192,557$6.95M0.0%+376.9%2.734% 5/16/2025Adage Capital Partners GP L.L.C.200,000$7.21M0.0%+50.9%2.839% 5/15/2025RA Capital Management L.P.206,427$7.45M0.1%-55.2%2.931% 5/15/2025OMERS ADMINISTRATION Corp14,000$505K0.0%N/A0.199% 5/14/2025Walleye Capital LLC85,022$3.07M0.0%-17.6%1.207% 2/17/2025Point72 Asset Management L.P.135,189$4.87M0.0%N/A3.049% 2/17/2025Millennium Management LLC40,379$1.45M0.0%N/A0.911% 2/17/2025Janus Henderson Group PLC508,776$18.39M0.0%N/A11.485% 2/17/2025Bank of America Corp DE4,793$173K0.0%N/A0.108% 2/17/2025Acuta Capital Partners LLC69,124$2.49M2.5%N/A1.560% 2/14/2025RA Capital Management L.P.460,829$16.60M0.2%N/A10.402% 2/14/2025Jane Street Group LLC6,600$238K0.0%N/A0.149% 2/14/2025Schonfeld Strategic Advisors LLC69,812$2.47M0.0%N/A1.576% 2/14/2025AdvisorShares Investments LLC3,075$111K0.0%-98.3%0.069% 2/14/2025Boothbay Fund Management LLC44,580$1.61M0.0%N/A1.006% 2/14/2025Adage Capital Partners GP L.L.C.132,500$4.77M0.0%N/A2.991% 2/14/2025Vivo Capital LLC251,572$9.06M1.0%N/A5.679% 2/13/2025Walleye Capital LLC103,192$3.72M0.0%N/A2.327% 2/13/2025Springhill Fund Asset Management HK Co Ltd60,648$2.19M3.5%N/A1.369% 2/13/2025Atika Capital Management LLC15,000$540K0.1%N/A0.339% 2/14/2024AdvisorShares Investments LLC188,119$273K0.1%+12.0%4.246% 11/6/2023AdvisorShares Investments LLC167,930$267K0.1%-67.4%4.452% 8/9/2023AdvisorShares Investments LLC515,315$294K0.1%+14.7%14.640% 5/9/2023AdvisorShares Investments LLC449,155$198K0.1%+42.7%2.553% 8/8/2022AdvisorShares Investments LLC289,576$237K0.1%+40.1%2.439% 5/9/2022AdvisorShares Investments LLC206,716$314K0.1%+115.5%1.745% 2/9/2022Checchi Capital Advisers LLC14,138$45K0.0%N/A0.119% 1/31/2022AdvisorShares Investments LLC95,942$304K0.0%N/A0.810% (Data available from 1/1/2016 forward) DRUG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DRUG shares? During the previous two years, 24 institutional investors and hedge funds held shares of Bright Minds Biosciences. The most heavily invested institutionals were Janus Henderson Group PLC ($18.39M), Sio Capital Management LLC ($13.38M), Perceptive Advisors LLC ($10.98M), Vivo Capital LLC ($9.06M), RA Capital Management L.P. ($7.45M), Adage Capital Partners GP L.L.C. ($7.21M), and Millennium Management LLC ($6.95M).Learn more on Bright Minds Biosciences' institutional investors. What percentage of Bright Minds Biosciences' stock is owned by institutional investors? 40.52% of Bright Minds Biosciences' stock is owned by institutional investors. Learn more on DRUG's institutional investor holdings. Which institutional investors have been buying Bright Minds Biosciences' stock? Of the 23 institutional investors that purchased Bright Minds Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($508.78K), RA Capital Management L.P. ($460.83K), Vivo Capital LLC ($251.57K), Adage Capital Partners GP L.L.C. ($200K), Millennium Management LLC ($192.56K), Point72 Asset Management L.P. ($135.19K), and Walleye Capital LLC ($103.19K). How much institutional buying is happening at Bright Minds Biosciences? Institutional investors have bought a total of 2,256,178 shares in the last 24 months. This purchase volume represents approximately $80.54M in transactions. Which of Bright Minds Biosciences' major shareholders have been selling company stock? The following institutional investors have sold Bright Minds Biosciences stock in the last 24 months: RA Capital Management L.P. ($254.40K), AdvisorShares Investments LLC ($179.35K), Walleye Capital LLC ($49.76K), Perceptive Advisors LLC ($23.96K), Acuta Capital Partners LLC ($11.27K), and Bank of America Corp DE ($682.00). How much institutional selling is happening at Bright Minds Biosciences? Institutional investors have sold a total of 519,424 shares in the last 24 months. This volume of shares sold represents approximately $18.05M in transactions. Related Companies Schrodinger Institutional Ownership Syndax Pharmaceuticals Institutional Ownership AbCellera Biologics Institutional Ownership Amphastar Pharmaceuticals Institutional Ownership Stoke Therapeutics Institutional Ownership Tilray Brands Institutional Ownership Evotec Institutional Ownership Arcus Biosciences Institutional Ownership Intellia Therapeutics Institutional Ownership Tourmaline Bio Institutional Ownership This page (NASDAQ:DRUG) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRUG Stock Alerts